Pharmaceutical Product For Treatment And/Or Prevention Of Cancer

Abstract: This pharmaceutical product is useful for the treatment and/or prevention of cancer and contains the following components combined with each other in a blended or separated form: an antibody or a fragment thereof having immunological reactivity with a CAPRIN-1 protein; and a PDGFR inhibitor.

Patent Information

Application #

Filing Date

12 February 2025

Publication Number

12/2025

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

TORAY INDUSTRIES, INC.

1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo 1038666

Inventors

1. WASAI Ukei

c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa 2488555

2. OKANO Fumiyoshi

c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa 2488555

3. SAITO Takanori

c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa 2488555

Specification

Documents

Application Documents

#	Name	Date
1	202517012048-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [12-02-2025(online)].pdf	2025-02-12
2	202517012048-STATEMENT OF UNDERTAKING (FORM 3) [12-02-2025(online)].pdf	2025-02-12
4	202517012048-Sequence Listing in txt [12-02-2025(online)].txt	2025-02-12
5	202517012048-Sequence Listing in PDF [12-02-2025(online)].pdf	2025-02-12
6	202517012048-REQUEST FOR EXAMINATION (FORM-18) [12-02-2025(online)].pdf	2025-02-12
7	202517012048-PROOF OF RIGHT [12-02-2025(online)].pdf	2025-02-12
8	202517012048-POWER OF AUTHORITY [12-02-2025(online)].pdf	2025-02-12
9	202517012048-FORM 18 [12-02-2025(online)].pdf	2025-02-12
10	202517012048-FORM 1 [12-02-2025(online)].pdf	2025-02-12
11	202517012048-FIGURE OF ABSTRACT [12-02-2025(online)].pdf	2025-02-12
12	202517012048-DRAWINGS [12-02-2025(online)].pdf	2025-02-12
13	202517012048-DECLARATION OF INVENTORSHIP (FORM 5) [12-02-2025(online)].pdf	2025-02-12
14	202517012048-COMPLETE SPECIFICATION [12-02-2025(online)].pdf	2025-02-12
15	202517012048-RELEVANT DOCUMENTS [21-02-2025(online)].pdf	2025-02-21
16	202517012048-MARKED COPIES OF AMENDEMENTS [21-02-2025(online)].pdf	2025-02-21
17	202517012048-FORM 13 [21-02-2025(online)].pdf	2025-02-21
18	202517012048-AMMENDED DOCUMENTS [21-02-2025(online)].pdf	2025-02-21
19	202517012048-certified copy of translation [16-05-2025(online)].pdf	2025-05-16
20	202517012048-FORM 3 [28-07-2025(online)].pdf	2025-07-28